Virginia Universities Launch Neuropathy Research Project
The collaborative effort aims to improve the understanding of chemotherapy-related nerve damage in breast cancer survivors.
Updated on Oct. 25, 2026 in Cancer
Live Poll
Should medical research funding prioritize improving long-term quality of life for cancer survivors?
George Mason University and Virginia Commonwealth University have launched a joint research project to better understand chemotherapy-induced peripheral neuropathy. This initiative, supported by new state funding, specifically aims to help breast cancer survivors.
Why it matters
Chemotherapy-induced nerve damage can significantly impact the long-term quality of life for cancer survivors. By better understanding the biological mechanisms of this condition, researchers hope to improve care and management strategies for those affected.
The Commonwealth Health Research Board awarded a $200,000 grant to fund a new collaborative study. The research remains in its early stages, as investigators work to analyze peripheral neuropathy specifically in breast cancer survivors.
The players
Nadine Kabbani
A researcher at George Mason University who leads the collaborative project on chemotherapy-related nerve damage.
Imad Damaj
A researcher at Virginia Commonwealth University who co-leads the study into peripheral neuropathy.
Paula Bos
A researcher at the VCU Massey Comprehensive Cancer Center who contributes to the collaborative research team.
Commonwealth Health Research Board
A state-level funding body that supports medical research initiatives across Virginia.
The details
The project brings together experts from George Mason University and Virginia Commonwealth University to investigate the causes and effects of peripheral neuropathy. This side effect occurs when chemotherapy agents damage nerves, typically leading to pain, numbness, or tingling in the hands and feet. Researchers aim to bridge expertise across institutions to study how these treatments alter nerve function in patients recovering from breast cancer.
Timeline
October 25, 2026: Announcement of the research collaboration.
Health Landscape
This effort follows the pattern set by other specialized studies hosted at the VCU Massey Comprehensive Cancer Center to address long-term survivorship issues. It represents a growing institutional focus on mitigating the chronic side effects associated with modern cancer treatment protocols.
If you are a breast cancer survivor experiencing persistent numbness or pain, it is worth discussing these symptoms with your oncologist to document them as part of your survivorship care plan. While this project is in the research phase, keeping a record of nerve-related symptoms helps your medical team better manage potential long-term side effects.
The takeaway
Understanding the lasting impact of chemotherapy is a critical part of post-treatment recovery for cancer survivors. Patients should track any new or worsening sensory changes in their extremities and report them during follow-up appointments to ensure their care team can provide appropriate supportive care.
Further reading
For more information on current treatment side effects and research, visit the Cancer section.
Source note: This article includes information reported by Potomac Local News.
Live Poll
Should medical research funding prioritize improving long-term quality of life for cancer survivors?
